Status:
UNKNOWN
Protocol to Support Breastfeeding for Postpartum Women and Mothers of Babies With Congenital Heart Disease
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Collaborating Sponsors:
Irmandade Santa Casa de Misericórdia de Porto Alegre
Conditions:
Breastfeeding
Congenital Heart Disease
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
To evaluate the effect of applying a hybrid protocol (face-to-face and via call center) of breastfeeding assistance and guidance on the duration of breast milk supply to babies with congenital heart d...
Detailed Description
The objective of this randomized, multicenter clinical trial is to evaluate the effect of applying a hybrid protocol (face-to-face and telemarketing) of assistance and guidance on breastfeeding and du...
Eligibility Criteria
Inclusion
- Infants diagnosed with congenital heart disease,
- The parents must have a cell phone enabled to receive video calls.
Exclusion
- Mothers carriers of the human immunodeficiency virus (HIV),
- Mothers users of medications without medical indication to initiate or maintain breastfeeding.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06025864
Start Date
July 1 2022
End Date
February 20 2024
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juliana Caprini
Caxias do Sul, Rio Grande do Sul, Brazil, 95080560